- Home
- RPRX vs KEY Comparison
RPRX vs KEY Comparison
Compare RPRX & KEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | KEY |
|---|---|---|
| Founded | 1996 | 1825 |
| Country | United States | United States |
| Employees | N/A | 17883 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 22.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | KEY |
|---|---|---|
| Price | $47.29 | $20.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $47.75 | $22.46 |
| AVG Volume (30 Days) | 2.9M | ★ 14.8M |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | 1.94% | ★ 4.01% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $15.33 |
| Revenue Next Year | $4.80 | $6.04 |
| P/E Ratio | $27.29 | ★ $14.43 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $30.04 | $12.80 |
| 52 Week High | $49.06 | $23.35 |
Technical Indicators
Market Signals| Indicator | RPRX | KEY |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 58.44 |
| Support Level | $44.84 | $20.33 |
| Resistance Level | $47.86 | $21.25 |
| Average True Range (ATR) | 0.92 | 0.45 |
| MACD | 0.11 | 0.21 |
| Stochastic Oscillator | 61.20 | 98.49 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About KEY KeyCorp
With assets of around $185 billion, Ohio-based KeyCorp's bank footprint spans 15 states, but it is predominantly concentrated in its three largest markets: Ohio, New York, and Washington. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.